Skip to main content

Published locations for Adjuvant erlotinib showed no benefit in NSCLC patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Adjuvant erlotinib showed no benefit in NSCLC patients

User login

  • Reset your password
  • /content/adjuvant-erlotinib-showed-no-benefit-nsclc-patients
  • /oncologypractice/article/102343/lung-cancer/adjuvant-erlotinib-showed-no-benefit-nsclc-patients
  • /node/155702/article/102343/lung-cancer/adjuvant-erlotinib-showed-no-benefit-nsclc-patients
  • /hematology-oncology/article/102343/lung-cancer/adjuvant-erlotinib-showed-no-benefit-nsclc-patients
  • /chestphysician/article/102343/lung-cancer/adjuvant-erlotinib-showed-no-benefit-nsclc-patients